Product Images Fingolimod
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Fingolimod NDC 60505-4332 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
btl-lbl - btl lbl
ctn-lbl - ctn lbl
This is a medication package containing 28 unit-dose capsules of fingolimod hydrochloride, with each capsule containing 0.5 mg of the medication. This package is equivalent to a four-week supply of medication, and the enclosed Medication Guide should be dispensed. The medication must be stored at room temperature between 15°C to 30°C (59°F to 86°F) and protected from moisture.*
Fingolimod chemical structure - fingo 01
Figure 1 Time to 3-month Confirmed Disability Progression – Study 1 (ITT population) - fingo 02
This text shows a graph indicating the percentage of patients with three-month confirmed progression in days after treatment with Fingolimod Capsules 0.5mg and Placebo. The X-axis represents time in days, and the Y-axis represents the percentage of patients. The data for Fingolimod Capsules is not available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.